Looking for the perfect treatment after successful atrial fibrillation ablation
Mattia Galli@MattiaGalli10
Can we drop oral anticoagulant therapy after successful atrial fibrillation ablation? academic.oup.com/ehjcvp/article…
English
EHJ-CVP Editor-in-Chief
158 posts
EHJ-CVP Editor-in-Chief
@EditorEHJCVP
#EHJPharmacotherapy Editor-in-Chief X account. Posts by @AgewallStefan and his team. @ESC_Journals #PharmaPulse #pharmacotherapy #cardiology #cardioed
Katılım Şubat 2024
247 Takip Edilen422 Takipçiler
@EditorEHJCVP
It is a pleasure to present the journal's new Impact Factor which increased to 6.1. I would like to express my gratitude to our eminent editorial board, our reviewers, our authors and to OUP
#escardio.org@esc_journals#cardiology@pharmacotherapy
English
@ESC_Journals
It is a pleasure to announce that the journals Impact Factor increased to 6.1 last year. I would like to express my gratitude to all the editorial team, to the reviewers, to our authors and to OUP
#Escardio.org #pharmacotherapy #cardiology@ESC_Journals
English
EHJ-CVP Editor-in-Chief retweetledi
Happening now: #ESCardioCRT is underway with a discussion focused on clear actions and pathways to be created for the improvement and harmonisation of #ESCGuidelines implementation at national level.
Thank you to all partners present contributing to building a blueprint that could serve as a model for National Cardiac Societies, ESC, allied professionals, health authorities, patient organisations and other cardiac and non-cardiac organisations for a uniform implementation.
#heartteam #cvhealth #CVD
English
EHJ-CVP Editor-in-Chief retweetledi
#EHJ: Consensus document on vaccination as CV prevention Vaccination is not only vital for preventing infectious diseases, it is also a proven strategy to reduce the risk of heart attacks, #heartfailure, and premature #cvdeath
Read our recently published evidence-based statement, which reinforces our ongoing commitment to science-driven public health, at a time when misinformation is putting lives at risk ow.ly/LgK550Wibck
Link to the press release: bit.ly/4nsBhn0
#HFA_ESC #EAPC_ESC #ACVC_ESC #COVID19 #infection #influenza #pneumococcus
English
EHJ-CVP Editor-in-Chief retweetledi
Prevention of #AFib with SGLT2-I across the spectrum of cardiovascular disorders: a meta-analysis of RCTs 📊
🔗 academic.oup.com/ehjcvp/advance…
#EHJPharmacotherapy 💊
@EditorEHJCVP 👔
@escardio @ESC_Journals 📚
English
EHJ-CVP Editor-in-Chief retweetledi
🆕 Long-term Antiplatelet Monotherapy after PCI: Searching for the smart choice 🔥 A new #Pharmapulse now online in #EHJPharmacotherapy 👉 ow.ly/lGzK50VOqH9
@EditorEHJCVP @FeliceGragnano @MattiaGalli10 @v_desio @paolocalabro1
English
EHJ-CVP Editor-in-Chief retweetledi
🧠 Stroke risk stratifications according to CHA2DS2-VASc vs. CHA2DS2-VA in patients with AF: new data from the GLORIA-AF registry now in #EHJPharmacotherapy 👉 ow.ly/Z94Q50VOqW8
@EditorEHJCVP @FeliceGragnano
English
EHJ-CVP Editor-in-Chief retweetledi
Looking back to our first meeting in 1949, the ESC is proud to celebrate a legacy of global members who contribute so much.
75 years of impact. 75 years of improving cardiovascular care.
Explore our story: ow.ly/EAs850VWWhw
#ESC75Years
English
EHJ-CVP Editor-in-Chief retweetledi
🧠💊 Is clopidogrel a *smart choice* for long-term antiplatelet monotherapy in patients with coronary artery disease? We share our perspective in our latest article in #EHJPharmacotherapy! 📖🔍
👉 academic.oup.com/ehjcvp/advance…
@paolocalabro1 @v_desio @MattiaGalli10 @EditorEHJCVP
English
Early use of SGLT2i after myocardial infarction
European Society of Cardiology Journals@ESC_Journals
🆕 Early use of #SGLT2i after myocardial infarction shows promise in reducing HF hospitalisations, but no mortality benefit 🚑❌⚰️ Is it time to rethink post-MI therapy? 🤔 Read more in #EHJPharmacotherapy 👉 ow.ly/gxg150VH0lA @EditorEHJCVP @FeliceGragnano @MattiaGalli10
English
Interesting data
Felice Gragnano@FeliceGragnano
🧠💊 Is clopidogrel a *smart choice* for long-term antiplatelet monotherapy in patients with coronary artery disease? We share our perspective in our latest article in #EHJPharmacotherapy! 📖🔍 👉 academic.oup.com/ehjcvp/advance… @paolocalabro1 @v_desio @MattiaGalli10 @EditorEHJCVP
Indonesia
Is albumin level associated with risk of major bleeding in patients with Afib on DOACs?
Felice Gragnano@FeliceGragnano
Albumin level and risk of major #bleeding in patients with #AFib on DOACs 🩸 New evidence now published with open access in #EHJPharmacotherapy 💊 📡 academic.oup.com/ehjcvp/advance… @EditorEHJCVP @ESC_Journals @escardio @ESCWGThrombosis #Cardiology #CardioEd #CardioTwitter
English
EHJ-CVP Editor-in-Chief retweetledi
Be where digital transformation happens.
#ESCAIsummit2025 is the gateway for cutting-edge digital solutions that are shaping #cvcare
From innovation to implementation – Showcase your breakthroughs and lead the change 👉
escardio.org/Congresses-Eve…
@SandyEngelh @BruiningNico @fwasselbergs @KarimLekadir @CMichaelGibson @Drroxmehran @DavidDuncker @EmmaSvennberg
#AIinHealthcare #DigitalHealth #HealthTech #DataScience #MedTech
English
EHJ-CVP Editor-in-Chief retweetledi
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy
Konstantin Krychtiuk@krychtiukmd
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy - joint effort by @escardio ACVC, EAPCI, EHRA, WG CVPT and @EAHADnews Kudos to @dan_atar for leading this complex but important project! academic.oup.com/ehjcvp/article…
English
SHould we use colchicine in patients with MI?
Nikos Pyrpyris@pyrpyris
#Colchicine in STEMI: #CLEAR results, #cloudy impact What do the conflicting results tell us❓ Do we need further studies❓ Is there an optimal patient #phenotype❓ 📍More at #EHJPharmacotherapy ➡️ academic.oup.com/ehjcvp/advance… #CardioX #Cardiology #Heart @EditorEHJCVP @ESC_Journals
English
EHJ-CVP Editor-in-Chief retweetledi
Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months academic.oup.com/eurheartj/arti…
English
Triple lipid lowering drugs
Mattia Galli@MattiaGalli10
Is triple therapy with statin, ezetimibe and bempedoic acid an option? Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia @FeliceGragnano @EditorEHJCVP @pyrpyris academic.oup.com/ehjcvp/article…
English
The EMPAG-HF trial unveils the acute effects of empagliflozin on left atrial and ventricular filling parameters using echocardiography in patients with HF
Felice Gragnano@FeliceGragnano
#EHJPharmacotherapy 💊 @EditorEHJCVP 👨💼 @escardio @ESC_Journals 📚
English
Frail persons are for sure a certain group of paetins
Stefan Agewall@AgewallStefan
Can we use DOAC in frail patients?
English